Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for the known COVID-19 disease. Since currently no definitive therapies or vaccines for the SARS-CoV-2 virus are available, there is an urgent need to identify effective drugs against SARS-CoV-2 infection. One of t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Biomol Struct Dyn
Egile Nagusiak: Fiorucci, Diego, Milletti, Eva, Orofino, Francesco, Brizzi, Antonella, Mugnaini, Claudia, Corelli, Federico
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7441760/
https://ncbi.nlm.nih.gov/pubmed/32705942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1796805
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak